Results 131 to 140 of about 24,819 (205)

Challenges and opportunities in the application of carbon nanotubes as membrane channels to improve mass transfer to cells. [PDF]

RSC Adv
Yazdani S, Biria D, Pazuki G.
europepmc   +1 more source

Pseudomonas aeruginosa Porin OprF [PDF]

Journal of Biological Chemistry, 2006
Ekaterina M. Nestorovich, Etsuko Sugawara, Hiroshi Nikaido, Sergey M. Bezrukov   +3 more
openaire   +1 more source

Molecular basis of ampicillin resistance: combinatorial mechanisms and future strategies. [PDF]

World J Microbiol Biotechnol
Türkyılmaz O, Darcan C.
europepmc   +1 more source

<i>In vitro</i> activity of cefepime/zidebactam against <i>Klebsiella pneumoniae</i> carrying <i>bla</i> _KPC variants conferring resistance to ceftazidime/avibactam. [PDF]

JAC Antimicrob Resist
Tascini C, Marshall SH, Bonomo RA, Gaibani P.   +3 more
europepmc   +1 more source

Porin-Independent Uptake of Small Molecule Antibiotics Facilitated by Escherichia coli Outer Membrane Vesicles. [PDF]

Biotechnol Bioeng
Wu M, Harrower RM, Li Z, Brown AC.
europepmc   +1 more source

Enhanced antibacterial activity of antimicrobial peptide-antibiotic combinations against multidrug-resistant bacteria. [PDF]

FEMS Microbes
Talha M, Roque-Borda CA.
europepmc   +1 more source

OmpK35/36 absence does not confer carbapenem-resistance alone nor ceftazidime-avibactam resistance with one <i>bla</i> _KPC-2. [PDF]

Front Cell Infect Microbiol
Wu S, Yang Y, Xiang W, Zhang J, Luo X, Xu M, Hu D, Zhang H.   +7 more
europepmc   +1 more source

Augmentation of antibacterial activity of ciprofloxacin by bisabololoxide A encapsulated in polymeric nanoparticles against uropathogenic Escherichia coli. [PDF]

BMC Biotechnol
Bazgosha M, Saberi GA, Hormozi M, Shirangi K, Shaghaghi Bahri F, Zahmatkesh H, Rasti B, Najafi F, Ranji N, Nikpassand M, Shahriarinour M.   +10 more
europepmc   +1 more source

Biogenesis of mitochondrial proteins [PDF]

, 1989
A Rietveld, A Rietveld, A Rietveld, A Rietveld, A Rietveld, AK Hopper, AL Horwich, B Chatton, B Hennig, B Hennig, B Schmid, C Zwizinski, C Zwizinski, CR Hackenbrock, D Ricquier, DW Nicholson, EC Hurt, EC Hurt, EC Hurt, EC Hurt, F Bouilland, F-U Hartl, F-U Hartl, F-U Hartl, G Hawlitschek, G Heijne von, G Natsoulis, GS Adrian, H Aquila, H Freitag, H Korb, H Riezmann, HJ Gabius, JG Conboy, JP Beltzer, K Mihara, K Mihara, K Verner, K Watanabe, KB Freeman, M Eilers, M Eilers, M Mori, M Nguyen, M Saraste, M Schleyer, M Schleyer, M Schwaiger, M Tropschug, M Wu, ME Dumont, MG Douglas, MP Yaffe, N Pfanner, N Pfanner, N Pfanner, N Pfanner, N Pfanner, N Pfanner, N Pfanner, N Pfanner, P Böhm, PC Böhni, PC McAda, R Kleene, R Pfaller, R Pfaller, R Zimmermann, R Zimmermann, RA Stuart, RG Ridley, S Matsuura, S Miura, S Miura, S Ohta, SD Emr, SM Gasser, SM Gasser, SM Gasser, T Hase, T Hase, T Sollner, W Neupert, W-J Chen, W-J Chen   +84 more
core   +1 more source

Impact of porin deletions on cefepime-taniborbactam activity against Klebsiella pneumoniae. [PDF]

Antimicrob Agents Chemother
Uehara T, Chatwin CL, Miller B, Edwards M, Stevenson A, Colombo J, Uehara K, Daigle DM.   +7 more
europepmc   +1 more source